制药股承压 默沙东(MRK)跌3.23% 机构称特朗普药品“最惠国”定价政策或给行业造成重大负担

金吾财讯
13 May

金吾财讯 | 制药股承压,默沙东(MRK)跌3.23%,报77.835美元;其余概念股中,葛兰素史克(GSK)跌2.84%,阿斯利康(AZN)跌1.68%,诺华制药(NVS)跌1.53%,安进 (AMGN)跌1.45%。泛欧投行Bryan Garnier分析师在一份报告中表示,尽管特朗普政府提出的药品“最惠国”定价政策在国会能否获得足够政治支持仍不确定,但这仍是制药行业的重大负担。分析师指出,特朗普在2020年首次任期内曾推行类似政策,但被联邦法官叫停,随后时任总统拜登于2021年废除。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10